|
ICK expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.158800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.042790E-01 |
| Normal-vs-Stage2 |
8.497000E-01 |
| Normal-vs-Stage3 |
7.872400E-01 |
| Normal-vs-Stage4 |
6.408800E-01 |
| Stage1-vs-Stage2 |
3.067800E-01 |
| Stage1-vs-Stage3 |
4.595400E-01 |
| Stage1-vs-Stage4 |
9.234200E-01 |
| Stage2-vs-Stage3 |
7.214200E-01 |
| Stage2-vs-Stage4 |
5.755000E-01 |
| Stage3-vs-Stage4 |
7.217800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.890040E-01 |
| Normal-vs-AfricanAmerican |
3.417600E-01 |
| Normal-vs-Asian |
1.346600E-01 |
| Caucasian-vs-AfricanAmerican |
1.641390E-01 |
| Caucasian-vs-Asian |
6.688200E-01 |
| AfricanAmerican-vs-Asian |
9.480100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.020000E-01 |
| Normal-vs-Female |
1.692030E-01 |
| Male-vs-Female |
5.148000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.648370E-01 |
| Normal-vs-Extreme_Weight |
5.037600E-03 |
| Normal-vs-Obese |
6.869600E-01 |
| Normal-vs-Extreme_Obese |
2.456800E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.679800E-01 |
| Normal_Weight-vs-Obese |
1.152550E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.776600E-01 |
| Extreme_Weight-vs-Obese |
5.095200E-03 |
| Extreme_Weight-vs-Extreme_Obese |
9.210600E-01 |
| Obese-vs-Extreme_Obese |
2.084800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.630800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.667200E-01 |
| Normal-vs-Age(61-80Yrs) |
4.390200E-02 |
| Normal-vs-Age(81-100Yrs) |
2.489600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.680800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.328800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.279600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.038100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.047700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.935400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.094600E-01 |
| Normal-VS-Type2 PRCC |
1.635200E-01 |
| Normal-VS-KIRP CIMP |
7.151200E-01 |
| Normal-VS-Unclassified PRCC |
3.200200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.966000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.722800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.079600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.152200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.614500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.296400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.171820E-02 |
| Normal-vs-N1 |
2.120200E-01 |
| Normal-vs-N2 |
6.776000E-03 |
| N0-vs-N1 |
1.025170E-01 |
| N0-vs-N2 |
2.922800E-01 |
| N1-vs-N2 |
4.109600E-02 |
|
|
